About heather

This author has not yet filled in any details.
So far heather has created 733 blog entries.

APDN Regains Compliance with Nasdaq Minimum Bid Price Requirement

STONY BROOK, N.Y., - May 10, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained [...]

2024-05-09T18:43:06-04:00Categories: Investors, Press Release|

Tests highlight Xinjiang cotton concerns

STONY BROOK - CHAMPAIGN - DNA and isotopic testing has revealed that 19% of all textile-based products tested contained cotton from the Xinjiang region of China which is banned in the US over forced labour concerns. Molecular technologies specialist Applied DNA Sciences (ADNAS) and Isotech Laboratories, part of the Stratum Reservoir group, tested 822 [...]

Banned Chinese cotton found in 19% of US and global retailers’ merchandise, study shows

NEW YORK, May 7 (Reuters) – Traces of banned Chinese cotton were found in 19% of a sample of merchandise selling at U.S. and global retailers in the past year, a study showed, highlighting the challenges of complying with the U.S. law aimed at blocking imports of cotton linked to forced labor in China. [...]

APDN Awarded Contract by HDT Bio For Rapid Vaccine Development Program

STONY BROOK, N.Y., April 25, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced the award of a contract from HDT Bio for the purpose of rapid, next-generation vaccine development under a ‘Project NextGen: Enabler’ award to HDT Bio (the “Project”). The Project seeks [...]

2024-04-25T09:01:06-04:00Categories: Linear DNA, Press Release, Vaccines|Tags: , |

Applied DNA Announces 1-For-20 Reverse Stock Split

STONY BROOK, N.Y. – April 22, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock, to be effective as of 12:01 a.m. Eastern Time on Thursday, April 25, 2024. Applied DNA common stock [...]

2024-05-13T15:08:36-04:00Categories: Investors, Press Release|

Applied DNA, Alphazyme Agreement for Scale-Up Linea™ RNAP

STONY BROOK, N.Y., and JUPITER, F.L. March 18, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of specialty enzymes used in the life sciences sector, have entered into an agreement under which [...]

2024-05-13T15:08:58-04:00Categories: Linear DNA, Press Release|Tags: , , , |

APDN to Showcase Linea™ DNA, Linea™ IVT Platforms at World Vaccine Congress

STONY BROOK, N.Y., March 14, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea™ IVT and Linea™ DNA platforms at the 24th Annual World Vaccine Congress, which will be held April 1 – 4, 2024. Applied DNA sales team members will be available during the [...]

2024-04-23T14:49:49-04:00Categories: Linear DNA, Press Release|

UFLPA enforcement versus the challenge of tracing cotton’s origin

There is growing clamour from the US apparel and textile industry to boost enforcement of the Uyghur Forced Labor Prevention Act (UFLPA), however there are a number of challenges that need to be overcome first for verifying cotton's origin, writes Robert P. Antoshak, Gherzi Textile Organization partner and MeiLin Wan, vice president, Applied DNA Sciences. [...]

2024-05-13T15:43:03-04:00Categories: APDN in the News, Cotton, CTsite, Textile and Apparel|

APDN Announces First Quarter Fiscal Year 2024 Financial Results

STONY BROOK, NY / ACCESSWIRE / February 8, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for its first fiscal quarter ended December 31, 2023. The Company’s Form 10-Q can be viewed at https://investors.adnas.com/sec-filings/. “We made substantial progress in advancing [...]

2024-05-10T13:58:03-04:00Categories: Investors, Press Release|
Go to Top